Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Salivary Gland Infection Companies

Salivary gland infections, also known as sialadenitis, can be caused by bacterial or viral infections leading to inflammation of the salivary glands. The treatment typically involves antibiotics or antiviral medications depending on the cause. While there may not be specific companies exclusively focused on salivary gland infections, pharmaceutical companies that develop antibiotics and antiviral medications may have products relevant to the treatment of such infections.

Salivary Gland Infection Key Companies

Latest Salivary Gland Infection Companies Update

Novartis receives Phase 3 trial success for Ilaris (canakinumab) in treating Sjogren's syndrome, a chronic autoimmune disease affecting salivary glands. This positive outcome could pave the way for expanded treatment options for patients with this condition.

Medtronic introduces the SialoCath™ System in Japan, a minimally invasive catheter system for treating sialadenitis, expanding its reach in the Asia-Pacific market.

St. Jude Medical releases its Parotid Mucosa Excision System (ParoMEX®) in South Korea, offering a minimally invasive option for managing chronic sialadenitis in parotid glands.

Olympus Corporation launches its new sialendoscopy system in China, providing improved visualization and access for minimally invasive salivary gland procedures.

Stryker Corporation partners with Auris Medical to develop and commercialize novel salivary gland infection treatment options, combining their expertise in medical devices and biopharmaceuticals.

List of Salivary Gland Infection Key Companies in the Market

AbbVie Inc. (US)

Allergan (Republic of Ireland)

AstraZeneca (UK)

FUJIFILM Holdings Corporation (Japan)

General Electric Company (US)

GlaxoSmithKline plc. (UK)

Johnson & Johnson Services Inc. (US)

Merck & Co.Inc. (US)

Pfizer Inc.(US)

Siemens Healthcare GmbH (Germany)

Salivary Gland Infection Market Highlights:

Salivary Gland Infection Market Size

Salivary Gland Infection Market Trends

Salivary Gland Infection Market Analysis

Salivary Gland Infection Market Share

Salivary Gland Infection Market Highlights:

Salivary Gland Infection Market Trends

Salivary Gland Infection Market Analysis

Salivary Gland Infection Market Share

Salivary Gland Infection Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.